Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Other Operating Expenses: 2011-2018

  • EyePoint Pharmaceuticals' Other Operating Expenses was N/A to $3.6 million in Q3 2018 from the same period last year, while for Sep 2018 it was $5.2 million, marking a year-over-year change of. This contributed to the annual value of $1.5 million for FY2018, which is N/A change from last year.
  • EyePoint Pharmaceuticals' Other Operating Expenses amounted to $3.6 million in Q3 2018, which was up 141.14% from $1.5 million recorded in Q2 2018.
  • EyePoint Pharmaceuticals' Other Operating Expenses' 5-year high stood at $3.6 million during Q3 2018, with a 5-year trough of -$4,000 in Q1 2014.
  • Its 1-year average for Other Operating Expenses is $2.6 million, with a median of $2.6 million in 2018.